NYSE:HQL

Tekla Life Sciences Investors - HQL Stock Forecast, Price & News

$13.66

-0.04 (-0.29%)

(As of 09/30/2022 12:00 AM ET)

Add

Compare

Today's Range: $13.55
▼
$14.01
50-Day Range: $13.39
▼
$16.31
52-Week Range: $13.03
▼
$21.64

Volume: 54,756 shs
Average Volume: 74,934 shs
Market Capitalization: $343.41 million

P/E Ratio: N/A
Dividend Yield: 10.73%
Price Target: N/A

About Tekla Life Sciences Investors (NYSE:HQL) Stock

Tekla Life Sciences Investors is a closed-ended equity mutual fund launched and managed by Tekla Capital Management LLC. The fund invests in public equity markets across the globe. It seeks to invest in stocks of companies operating in the life sciences sector, including the biotechnology, pharmaceutical, diagnostics, managed healthcare, medical equipment, hospitals, healthcare information technology and services, devices and supplies industries, and in agriculture and environmental management industries. The fund primarily invests in growth stocks of small cap companies. It employs fundamental analysis with a focus on factors such as market position for services or products, experience of business management, technological expertise, and the ability either to generate funds internally to finance growth or to secure outside sources of capital to create its portfolio. The fund benchmarks the performance of its portfolio against the NASDAQ Biotech Index and the S&P 500 Index. It was formerly known as H&Q Life Sciences Investors fund. Tekla Life Sciences Investors was formed on February 20, 1992 and is domiciled in the United States.

Receive HQL Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Tekla Life Sciences Investors and its competitors with MarketBeat's FREE daily newsletter.

HQL Stock News Headlines

October 1, 2022 | americanbankingnews.com

Tekla Life Sciences Investors (NYSE:HQL) Sees Large Growth in Short Interest

July 14, 2022 | seekingalpha.com

HQL: A Biotechnology Equity CEF With No Leverage

May 17, 2022 | seekingalpha.com

Tekla Life Sciences cuts dividend by 10% to $0.35

April 27, 2022 | seekingalpha.com

HQL: Buy For The Yield, If You Can Stomach The Depreciation

January 18, 2022 | nasdaq.com

Tekla Life Sciences Investors Shares Approach 52-Week Low - Market Mover

August 15, 2021 | forbes.com

5 Dividend Funds Yielding Up To 27.2%

August 13, 2021 | nasdaq.com

Tekla Life Sciences Investors Shares Close in on 52-Week High - Market Mover

February 17, 2021 | benzinga.com

Tekla Life Sciences Increases Dividend From $0.40 To $0.43

December 21, 2020 | finance.yahoo.com

Tekla Life Sciences Investors Declares Cash Distribution

November 24, 2020 | benzinga.com

Understanding Tekla Life Sciences's Ex-Dividend Date

November 16, 2020 | finance.yahoo.com

Tekla Life Sciences Investors Declares Distribution

November 9, 2020 | seekingalpha.com

HQH: Deep Discount Leads To High Yield

May 15, 2020 | www.nasdaq.com

HQL TeklaLife Sciences Investors Common Stock

March 19, 2020 | finance.yahoo.com

Tekla Life Sciences Investors Announce Renewal of Share Repurchase Program

February 18, 2020 | seekingalpha.com

Tekla Life Sciences declares $0.39 dividend

February 18, 2020 | finance.yahoo.com

Tekla Life Sciences Investors Declares Stock Distribution

January 24, 2020 | finance.yahoo.com

Top Picks 2020- Tekla Life Sciences Fund HQL

October 11, 2019 | markets.ft.com

Tekla Life Sciences Investors

October 11, 2019 | realmoney.thestreet.com

Tekla Life Sciences Investors of Benef Interest

August 28, 2019 | finance.yahoo.com

Tekla Life Sciences Investors (HQL)

August 10, 2019 | seekingalpha.com

HQL: Healthcare Offers A Defensive Play For A Volatile Market With Solid Growth Potential

January 25, 2019 | finance.yahoo.com

Top Picks 2019- Tekla Life Sciences Investors HQL

See More Headlines

30 days | 90 days | 365 days | Advanced Chart

Receive HQL Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Tekla Life Sciences Investors and its competitors with MarketBeat's FREE daily newsletter.

HQL Company Calendar

Ex-Dividend for 9/30 Dividend: 8/25/2022
Dividend Payable: 9/30/2022
Today: 10/02/2022
Fiscal Year End: 9/30/2023

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: NYSE
Industry: Investment offices, not elsewhere classified
Sub-Industry: N/A
Sector: Finance
Current Symbol: NYSE:HQL
CUSIP: N/A
CIK: 884121
Web: www.teklacap.com
Phone: (617) 772-8500
Fax: 617-772-8577
Employees: N/A
Year Founded: N/A

Profitability

EPS (Most Recent Fiscal Year): N/A
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: N/A
Net Margins: N/A
Pretax Margin: N/A
Return on Equity: N/A
Return on Assets: N/A

Debt

Debt-to-Equity Ratio: N/A
Current Ratio: N/A
Quick Ratio: N/A

Sales & Book Value

Annual Sales: N/A
Price / Sales: N/A
Cash Flow: N/A
Price / Cash Flow: N/A
Book Value: N/A
Price / Book: N/A

Miscellaneous

Outstanding Shares: 25,140,000
Free Float: 22,615,000
Market Cap: $343.41 million
Optionable: Not Optionable
Beta: 0.82

Key Executives

Dr. Daniel R. Omstead M.S (Age 69)
Ph.D., Principal Exec. Officer, Pres and Trustee

Key Competitors

View All Competitors

Insiders & Institutions

View All Insider Transactions
View All Institutional Transactions

HQL Stock - Frequently Asked Questions

How have HQL shares performed in 2022?: Tekla Life Sciences Investors' stock was trading at $19.23 at the beginning of the year. Since then, HQL shares have decreased by 29.0% and is now trading at $13.66.
View the best growth stocks for 2022 here.
Are investors shorting Tekla Life Sciences Investors?: Tekla Life Sciences Investors saw a increase in short interest in September. As of September 15th, there was short interest totaling 36,300 shares, an increase of 80.6% from the August 31st total of 20,100 shares. Based on an average trading volume of 74,500 shares, the days-to-cover ratio is currently 0.5 days.
View Tekla Life Sciences Investors' Short Interest.
How often does Tekla Life Sciences Investors pay dividends? What is the dividend yield for Tekla Life Sciences Investors?: Tekla Life Sciences Investors announced a quarterly dividend on Wednesday, August 17th. Shareholders of record on Friday, August 26th will be paid a dividend of $0.31 per share on Friday, September 30th. This represents a $1.24 annualized dividend and a yield of 9.08%. The ex-dividend date is Thursday, August 25th.
Read our dividend analysis for HQL.
Is Tekla Life Sciences Investors a good dividend stock?: Tekla Life Sciences Investors (NYSE:HQL) pays an annual dividend of $1.47 per share and currently has a dividend yield of 10.73%. HQL has a dividend yield higher than 75% of all dividend-paying stocks, making it a leading dividend payer.
Read our dividend analysis for HQL.

What other stocks do shareholders of Tekla Life Sciences Investors own?: Based on aggregate information from My MarketBeat watchlists, some companies that other Tekla Life Sciences Investors investors own include NVIDIA (NVDA), Energy Transfer (ET), QUALCOMM (QCOM), AT&T (T), Enbridge (ENB), International Business Machines (IBM), Kinder Morgan (KMI), Main Street Capital (MAIN), Pfizer (PFE) and Weyerhaeuser (WY).
What is Tekla Life Sciences Investors' stock symbol?: Tekla Life Sciences Investors trades on the New York Stock Exchange (NYSE) under the ticker symbol "HQL."
How do I buy shares of Tekla Life Sciences Investors?: Shares of HQL stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.
What is Tekla Life Sciences Investors' stock price today?: One share of HQL stock can currently be purchased for approximately $13.66.
How much money does Tekla Life Sciences Investors make?: Tekla Life Sciences Investors (NYSE:HQL) has a market capitalization of $343.41 million.
How can I contact Tekla Life Sciences Investors?: Tekla Life Sciences Investors' mailing address is 2 LIBERTY SQUARE 9TH FLOOR, BOSTON MA, 02109. The official website for the company is www.teklacap.com. The company can be reached via phone at (617) 772-8500, via email at info@teklacap.com, or via fax at 617-772-8577.

This page (NYSE:HQL) was last updated on 10/2/2022 by MarketBeat.com Staff

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial

MarketBeat Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms